title: Octreotide: Jack-of-all-trades or expensive orphan?
mesh_terms: D000172:Acromegaly / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007340:Insulinoma / Q000188:drug therapy; D015282:Octreotide; D009965:Orphan Drug Production; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D010911:Pituitary Neoplasms / Q000188:drug therapy; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003969:Vipoma / Q000188:drug therapy; D015043:Zollinger-Ellison Syndrome / Q000188:drug therapy
chemical_list: D000970:Antineoplastic Agents; D013004:Somatostatin; D015282:Octreotide